ReviewBMC neurology2026
Segmental zoster paresis of the lower limb with multisegmental lumbosacral plexus involvement: a case report and literature review.
Review in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSegmental zoster paresis (SZP) of the lower limbs is an uncommon complication of herpes zoster (HZ). Its atypical presentation and variable prognosis make early recognition and comprehensive intervention essential. We describe a patient who developed sciatica, ipsilateral herpetic vesicles on the calf, and subsequent lower limb paralysis but achieved full functional recovery within two months. CASE PRESENTATION: A 73-year-old man presented with a 6-day history of persistent left lower back pain radiating to the left lower limb. He was initially diagnosed with sciatica after lumbar magnetic resonance imaging (MRI) revealed disc abnormalities. The appearance of scattered erythematous vesicles along the left L4-L5 dermatomes led to a revised diagnosis of HZ, prompting the initiation of antiviral, corticosteroid, and analgesic therapies. One week after the resolution of the rash, the patient developed new-onset motor weakness in the left leg; manual muscle testing demonstrated grade 3-/5 strength in the left iliopsoas and quadriceps femoris. Laboratory tests revealed dysglycemia and T-cell dysfunction. Electrophysiological studies confirmed neurogenic involvement of the L2-S1 spinal segments, establishing the diagnosis of SZP secondary to HZ. Following continued neurotrophic therapy and structured, intensive rehabilitation, the patient demonstrated progressive improvement, achieving complete motor recovery within two months.
conclusionsEarly identification of risk factors, timely diagnosis, and aggressive multimodal management are crucial for optimizing functional recovery in individuals with lower limb SZP. Enhanced clinical awareness is essential to prevent long-term disability and avoid unnecessary interventions. Further studies are needed to establish standardized treatment guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.